Q2 2023 Holdings
Filed 2023-08-08 | 61 holdings | $328.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Gilead Sciences(GILD) | COM | 375558103 | $11.1M | 144,584 | 3.4% |
| Intra-Cellular Therapies(ITCIEUR) | COM | 46116X101 | $11.2M | 176,856 | 3.4% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $11.6M | 52,759 | 3.5% |
| Apellis Pharms.(APLS) | COM | 03753U106 | $11.8M | 129,700 | 3.6% |
| Alnylam Pharms.(ALNY) | COM | 02043Q107 | $15.5M | 81,600 | 4.7% |
| Vera Therapeutics(VERA) | CL A | 92337R101 | $15.6M | 975,227 | 4.8% |
| Supernus Pharms.(SUPN) | COM | 868459108 | $15.7M | 523,500 | 4.8% |
| Regeneron Pharms.(REGN) | COM | 75886F107 | $19.4M | 27,000 | 5.9% |
| Harmony Biosciences Hldgs(HRMY) | COM | 413197104 | $20.1M | 570,500 | 6.1% |
| Incyte Corp(INCY) | COM | 45337C102 | $22.3M | 358,454 | 6.8% |
| Amgen Inc COM(AMGN) | COM | 031162100 | $26.0M | 117,246 | 7.9% |